医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2014年
7期
119-119
,共1页
氨曲南%治疗%下呼吸道感染%临床观察
氨麯南%治療%下呼吸道感染%臨床觀察
안곡남%치료%하호흡도감염%림상관찰
Aztreonam%Treatment%Lower respiratory infection%Clinical observation
目的:探讨氨曲南治疗下呼吸道感染的临床治疗效果和不良事件情况,为提高患者呼吸道感染治愈率提供参考。方法选择我院2010年~2012年收治的200例下呼吸道感染患者,通过数字对照法随机分成两组,一组为治疗组100例,采用氨曲南进行治疗;另一组为对照组100例,采用头孢他啶进行治疗,对两组的治疗情况进行对比分析。结果治疗组有62例患者治疗效果显效,总有效率92.0%;对照组有45例患者显效,总有效率72.0%。通过统计分析可知治疗组的治疗效果显著好于对照组,P<0.05。结论氨曲南对于治疗下呼吸道感染效果显著,其特点是抗菌谱广、抑制细菌繁殖力强、机体易于吸收和不良事件发生率低等,在临床上适于推广用于下呼吸道感染的治疗。
目的:探討氨麯南治療下呼吸道感染的臨床治療效果和不良事件情況,為提高患者呼吸道感染治愈率提供參攷。方法選擇我院2010年~2012年收治的200例下呼吸道感染患者,通過數字對照法隨機分成兩組,一組為治療組100例,採用氨麯南進行治療;另一組為對照組100例,採用頭孢他啶進行治療,對兩組的治療情況進行對比分析。結果治療組有62例患者治療效果顯效,總有效率92.0%;對照組有45例患者顯效,總有效率72.0%。通過統計分析可知治療組的治療效果顯著好于對照組,P<0.05。結論氨麯南對于治療下呼吸道感染效果顯著,其特點是抗菌譜廣、抑製細菌繁殖力彊、機體易于吸收和不良事件髮生率低等,在臨床上適于推廣用于下呼吸道感染的治療。
목적:탐토안곡남치료하호흡도감염적림상치료효과화불량사건정황,위제고환자호흡도감염치유솔제공삼고。방법선택아원2010년~2012년수치적200례하호흡도감염환자,통과수자대조법수궤분성량조,일조위치료조100례,채용안곡남진행치료;령일조위대조조100례,채용두포타정진행치료,대량조적치료정황진행대비분석。결과치료조유62례환자치료효과현효,총유효솔92.0%;대조조유45례환자현효,총유효솔72.0%。통과통계분석가지치료조적치료효과현저호우대조조,P<0.05。결론안곡남대우치료하호흡도감염효과현저,기특점시항균보엄、억제세균번식력강、궤체역우흡수화불량사건발생솔저등,재림상상괄우추엄용우하호흡도감염적치료。
Objective To investigate the clinical therapeutic ef ect of aztreonam in the treatment of lower respiratory tract infections and adverse events, in order to improve the cure rate of patients with respiratory tract infection and provide reference. Methods 2010-2012 hospital treated 200 cases of lower respiratory tract infection patients, through the digital control method were randomly divided into two groups, one group was the treatment group of 100 cases, using the aztreonam treatment; the other group was 100 cases in the control group, were treated with ceftazidime, comparative analysis of treatment two group. Results 62 patients in the treatment group treatment ef ect, the total ef iciency of 92%;control group of 45 cases markedly ef ective, the total ef ective rate was 72%. Through the statistical analysis shows that the therapeutic ef ect of the treatment group was significantly bet er than the control group, P<0.05. Conclusion aztreonam for significant ef ect in treatment of lower respiratory tract infection, which is characterized by broad antibacterial spectrum, high fecundity, inhibiting bacteria could be absorbed and incidence of adverse events was low, suitable for promotion in clinic for the treatment of lower respiratory tract infection.